US Stock MarketDetailed Quotes

PHVS Pharvaris

Watchlist
  • 18.830
  • -0.100-0.53%
Close Dec 24 13:00 ET
1.02BMarket Cap-6.96P/E (TTM)

About Pharvaris Company

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Company Profile

SymbolPHVS
Company NamePharvaris
Listing DateFeb 5, 2021
Issue Price20.00
Founded2015
CEOMr. Berndt Modig
MarketNASDAQ
Employees82
Fiscal Year Ends12-31
AddressEmmy Noetherweg 2
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 BK
Phone31-71-203-64-10

Company Executives

  • Name
  • Position
  • Salary
  • Berndt Modig
  • Chief Executive Officer and Executive Director
  • 935.28K
  • Dr. Wim Souverijns, PhD
  • Chief Community Engagement and Commercial Officer
  • --
  • Joan Schmidt
  • Chief Legal Officer
  • --
  • Dr. Stefan Abele, PhD
  • Chief Technical Operations Officer
  • --
  • Dr. Peng Lu, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Anne Lesage, PhD
  • Chief Early Development Officer
  • --
  • Dr. Morgan Conn, PhD
  • Chief Business Officer
  • --
  • Annick Deschoolmeester
  • Chief Human Resources Officer
  • --
  • Anna Nijdam, M.Sc.
  • Head of Strategic Finance and Principal Accounting Officer
  • --
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 45.00K
  • Dr. David P. Meeker,M.D.
  • Independent Director
  • 94.00K
  • Viviane Monges
  • Independent Director
  • 62.50K
  • Dr. Robert Glassman, M.D.
  • Independent Director
  • 50.50K
  • Hans Schikan, Pharm.D.
  • Independent Director
  • 61.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data